Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 751 Jan 1 – Oct 25, 2026
- Disclosed funding
- $25.9B 611 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| N NanoZymeXCompany profile NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. | €160K | Pre-SeedPre-seed | Healthtech, Biotech | Switzerland | Investors | |
| ET Develops novel therapies for beta globin disorders | $32M | GrantUndisclosed | Healthtech, Biotech | United States | Investors | |
 Amani TherapeuticsCompany profile Biotechnology company developing combination medicines for serious neuropsychiatric disorders. Biotechnology company developing combination medicines for serious neuropsychiatric disorders. | $25M | Series A | Healthtech, Biotech | United States | Investors | |
| FC Provides doula care for pregnant and postpartum patients. | $5.7M | Seed | Healthtech | United States | Investors | |
 Earendil LabsCompany profile Earendil Labs develops protein therapeutics using AI models coupled with experimental antibody discovery and validation. Earendil Labs develops protein therapeutics using AI models coupled with experimental antibody discovery and validation. | Undisclosed | Financing rounds disclosureUndisclosed | Healthtech, Biotech | United States | Investors | |
| C CarecubesCompany profile Develops isolation units to prevent infectious disease transmission in healthcare settings Develops isolation units to prevent infectious disease transmission in healthcare settings | $6.5M | Series A | Healthtech | United States | Investors | |
| P Develops AI agents to automate hospital administrative workflows | $20M | Series A | Healthtech | France | Investors | |
| HU Health UniverseCompany profile Provides AI infrastructure for healthcare organizations to integrate and govern autonomous agents Provides AI infrastructure for healthcare organizations to integrate and govern autonomous agents | $6M | Seed | Healthtech | United States | Investors | |
| ET Excalipoint TherapeuticsCompany profile Develops next-generation T-cell engager therapies for cancer and autoimmune diseases Develops next-generation T-cell engager therapies for cancer and autoimmune diseases | $27.7M | Seed+Seed | Healthtech, Biotech | China | Investors | |
| HL Automates data collection in hospital environments. | €2.1M | Seed | Healthtech | Spain | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.